as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹1,793.2
Change
+64.6 (3.74%)
Open
₹1,749.5
Prev. Close
₹1,728.6
Day High
₹1,804.0
Day Low
₹1,731.1
Volume Analysis
Traded
66,589
Delivered
28,727
Delivery %
43.14%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Trading within 3% of its 52-week high (₹1839.0)
Weaknesses (1)
- •Low return on equity (5.54%)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹1,894.0 | ₹1,849.0 | ₹1,821.1 | ₹1,776.1 | ₹1,748.2 | ₹1,703.2 | ₹1,675.3 |
| Fibonacci | ₹1,849.0 | ₹1,821.15 | ₹1,803.95 | ₹1,776.1 | ₹1,748.25 | ₹1,731.05 | ₹1,703.2 |
| Camarilla | ₹1,813.25 | ₹1,806.57 | ₹1,799.88 | ₹1,776.1 | ₹1,786.52 | ₹1,779.84 | ₹1,773.15 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+35.37%
1 Week
+1.82%
1 Month
+10.01%
3 Months
+50.15%
6 Months
+62.46%
1 Year
+77.44%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹367.59
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
5.91%
Net margin 9.17% × asset turnover 0.5x × equity multiplier 1.29x
Company Overview
Sector
Chemicals
Market Cap
₹4,195 Cr
P/E (TTM)
80.1
ROE
5.54%
Book Value
₹334.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Tatva Chin Pharm Chem Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 50/100. The strongest factor is Financial Strength (100/100), while Cash Flow (15/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week high (₹1839.0); low return on equity (5.54%).
TopFund Score — Fundamentals Quality
50/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is expected to give good quarter
- +Company has been maintaining a healthy dividend payout of 22.5%
- +Company's working capital requirements have reduced from 133 days to 92.0 days
- −Stock is trading at 5.37 times its book value
- −The company has delivered a poor sales growth of 11.0% over past five years.
- −Company has a low return on equity of 3.68% over last 3 years.
- −Promoter holding has decreased over last 3 years: -7.15%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Trading window closed from 1 October 2026 until 48 hours after Q2 FY2026-27 results.
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (LODR) Regulations, 2015.
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (LODR) Regulations, 2015.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 114 | 97 | 84 | 98 | 105 | 83 | 86 | 108 | 117 | 124 | 131 | 134 | 167 |
| Expenses + | 93 | 76 | 73 | 83 | 93 | 78 | 79 | 99 | 100 | 101 | 106 | 106 | 135 |
| Operating Profit | 21 | 20 | 11 | 16 | 13 | 6 | 7 | 9 | 17 | 22 | 25 | 28 | 32 |
| OPM % | 19.0% | 21.0% | 13.0% | 16.0% | 12.0% | 7.0% | 8.0% | 8.0% | 15.0% | 18.0% | 19.0% | 21.0% | 19.0% |
| Other Income + | 1 | 1 | 1 | 5 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 0 | 1 |
| Interest | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 |
| Depreciation | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 10 | 11 |
| Profit before tax | 13 | 11 | 5 | 14 | 7 | -1 | 0 | 2 | 9 | 14 | 18 | 17 | 21 |
| Tax % | 29.0% | 31.0% | 34.0% | 30.0% | 24.0% | -34.0% | -165.0% | 49.0% | 27.0% | 27.0% | 14.0% | 38.0% | 24.0% |
| Net Profit + | 10 | 8 | 3 | 10 | 5 | -1 | 0 | 1 | 7 | 10 | 15 | 10 | 16 |
| EPS in Rs | 4 | 3 | 1 | 4 | 2 | 0 | 0 | 0 | 3 | 4 | 6 | 4 | 7 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 136 | 206 | 263 | 300 | 434 | 424 | 394 | 383 | 506 | 556 |
| Expenses + | 113 | 172 | 208 | 234 | 325 | 363 | 325 | 348 | 412 | 448 |
| Operating Profit | 23 | 34 | 55 | 67 | 109 | 61 | 69 | 35 | 94 | 108 |
| OPM % | 17.0% | 17.0% | 21.0% | 22.0% | 25.0% | 14.0% | 17.0% | 9.0% | 18.0% | 19.0% |
| Other Income + | 1 | 1 | 1 | 5 | 9 | 2 | 7 | 2 | 3 | 4 |
| Interest | 3 | 4 | 4 | 4 | 5 | 9 | 7 | 2 | 3 | 5 |
| Depreciation | 3 | 4 | 5 | 7 | 8 | 10 | 26 | 28 | 37 | 38 |
| Profit before tax | 19 | 27 | 48 | 61 | 104 | 45 | 44 | 8 | 57 | 69 |
| Tax % | 35.0% | 25.0% | 21.0% | 14.0% | 8.0% | -2.0% | 30.0% | 25.0% | 26.0% | — |
| Net Profit + | 12 | 21 | 38 | 52 | 96 | 45 | 30 | 6 | 42 | 51 |
| EPS in Rs | 15 | 26 | 47 | 26 | 43 | 21 | 13 | 2 | 18 | 22 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 19.0% | 5.0% | 10.0% | 15.0% | 41.0% | 11.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Reserves | 51 | 72 | 110 | 146 | 451 | 493 | 714 | 715 | 758 |
| Borrowings + | 56 | 77 | 91 | 90 | 120 | 170 | 14 | 36 | 120 |
| Other Liabilities + | 28 | 31 | 41 | 59 | 65 | 74 | 67 | 61 | 102 |
| Total Liabilities | 144 | 188 | 249 | 315 | 658 | 759 | 819 | 836 | 1,004 |
| Fixed Assets + | 57 | 67 | 111 | 120 | 160 | 196 | 427 | 529 | 609 |
| CWIP | 10 | 6 | 5 | 10 | 51 | 231 | 77 | 24 | 25 |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 4 |
| Other Assets + | 76 | 115 | 133 | 185 | 447 | 332 | 305 | 283 | 365 |
| Total Assets | 144 | 188 | 249 | 315 | 658 | 759 | 819 | 836 | 1,004 |
| Equity Capital | 8 | 8 | 8 | 20 | 22 | 22 | 23 | 23 | 23 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 13 | 7 | 25 | 20 | 20 | 28 | 98 | 25 | 31 |
| Cash from Investing Activity + | -30 | -17 | -40 | -21 | -197 | -101 | -121 | -65 | -116 |
| Cash from Financing Activity + | 7 | 17 | 10 | -5 | 235 | 38 | 31 | 17 | 79 |
| Net Cash Flow | -10 | 8 | -5 | -6 | 59 | -36 | 8 | -24 | -6 |
| CFO/OP | 105 | 39 | 61 | 44 | 36 | 61 | 157 | 85 | 42 |
| Free Cash Flow | -18 | -2 | -23 | -1 | -69 | -175 | -30 | -51 | -82 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 9.79% | 10.72% | 11.49% | 13.97% | 17.81% | 18.27% | 19.21% | 19.6% | 20.72% | 20.49% | 21.16% | 20.94% |
| Promoters | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% |
| FII | 4.4% | 4.21% | 3.65% | 3.37% | 3.33% | 3.36% | 3.3% | 3.26% | 3.4% | 4.17% | 3.81% | 3.93% |
| DII | 13.78% | 13.06% | 12.84% | 10.64% | 6.83% | 6.34% | 5.46% | 5.11% | 3.87% | 3.32% | 2.99% | 3.11% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Tatva Chin Pharm Chem Ltd (this stock) | 4,195 | 80.1 | 5.37 | 5.54% |
| Dhanuka Agritech Ltd | 4,385 | 15.0 | 3.16 | 22.0% |
| Grauer & Weil Ind Ltd | 3,920 | 24.5 | 3.62 | 15.2% |
| Prasol Chemicals Limited | 4,474 | 103.0 | — | 12.6% |
| Rallis India Ltd | 3,897 | 24.7 | 2.29 | 9.61% |
| Ghcl Limited | 3,881 | 8.5 | 1.09 | 13.0% |
| Gujarat Alkalies & Chem | 4,605 | 69.4 | 0.89 | -0.05% |
Which Mutual Funds Hold Tatva Chin Pharm Chem Ltd?
Frequently Asked Questions about Tatva Chin Pharm Chem Ltd
Tatva Chin Pharm Chem Ltd (TATVA) closed at ₹1,793.2 on NSE on 25 September 2026, up 64.6 (3.74%) from the previous close.
Tatva Chin Pharm Chem Ltd trades on the NSE (National Stock Exchange of India) under the symbol TATVA.
Tatva Chin Pharm Chem Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 80.1.
Tatva Chin Pharm Chem Ltd has a dividend yield of 0.11%.
Tatva Chin Pharm Chem Ltd's 52-week high is ₹1,839.0 and its 52-week low is ₹982.0.
Tatva Chin Pharm Chem Ltd has a market capitalisation of ₹4,195 crore.
Tatva Chin Pharm Chem Ltd has a TopFund Quality Score of 50/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Tatva Chin Pharm Chem Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.